— Know what they know.
Not Investment Advice

CYTK NASDAQ

Cytokinetics, Incorporated
1W: -3.8% 1M: -7.0% 3M: -21.5% YTD: -0.3% 1Y: +6.4% 3Y: +85.8% 5Y: +74.2%
$61.52
+0.79 (+1.30%)
 
Weekly Expected Move ±4.2%
$56 $59 $61 $64 $66
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 31 · $8.6B mcap · 134M float · 1.51% daily turnover · Short 60% of daily vol
Credit Risk of going bust: lower than 65% of companies Debt: 12.9% of company value Bonds: $54.9M held by 45 funds → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.74 (down 99%), Cytokinetics, Incorporated would be worth roughly what it owes.
Total debt $1.27B against a stock market value of $8.55B.
Distance to default 6.88 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $587.2M (short-term plus half of long-term), stock volatility 42.0%; Altman Z'' -6.09. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
37.9 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: 811.2%
Cost Advantage
34
Intangibles
48
Switching Cost
29
Network Effect
52
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CYTK has No discernible competitive edge (37.9/100). The business operates without significant structural advantages. The primary source of advantage is Network Effects. ROIC of 811.2% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$104
Low
$110
Avg Target
$113
High
Based on 6 analysts since Aug 6, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 34Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$110.50
Analysts6
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-14 UBS Ashwani Verma $115 $104 -11 +68.8% $61.62
2026-10-08 RBC Capital Leonid Timashev $112 $113 +1 +87.7% $60.21
2026-08-13 Barclays — $87 $110 +23 +45.4% $75.64
2026-08-10 Truist Financial Srikripa Devarakonda $106 $112 +6 +46.5% $76.44
2026-08-07 Needham Serge Belanger $84 $112 +28 +46.7% $76.32
2026-08-07 RBC Capital Leonid Timashev $117 $112 -5 +44.3% $77.59
2026-07-07 RBC Capital Leonid Timashev $119 $117 -2 +36.7% $85.57
2026-06-29 UBS Ashwani Verma $119 $115 -4 +39.9% $82.19
2026-06-24 Mizuho Securities — $99 $118 +19 +47.5% $80.01
2026-06-17 RBC Capital Leonid Timashev $101 $119 +18 +58.2% $75.21
2026-05-11 H.C. Wainwright — $136 $140 +4 +82.0% $76.91
2026-05-06 Morgan Stanley — $90 $103 +13 +39.5% $73.82
2026-05-06 UBS — $69 $119 +50 +60.1% $74.34
2026-05-06 Stifel Nicolaus — $96 $108 +12 +40.1% $77.09
2026-05-05 Truist Financial Srikripa Devarakonda $92 $106 +14 +38.4% $76.59
2026-04-10 Wells Fargo — Initiated $95 — +46.9% $64.66
2026-03-10 Robert W. Baird Roanna Ruiz Initiated $84 — +32.2% $63.55
2026-03-06 UBS Ashwani Verma $61 $69 +8 +13.9% $60.59
2026-02-20 RBC Capital — $95 $101 +6 +48.2% $68.13
2026-02-03 Truist Financial Srikripa Devarakonda $84 $92 +8 +38.4% $66.47
2026-01-09 Jefferies Akash Tewari $85 $90 +5 +42.3% $63.24
2026-01-08 Morgan Stanley Maxwell Skor $71 $90 +19 +37.9% $65.25
2025-12-22 Truist Financial Srikripa Devarakonda $60 $84 +24 +24.8% $67.33
2025-12-22 Morgan Stanley — $67 $71 +4 +5.4% $67.39
2025-12-22 Leerink Partners Roanna Ruiz Initiated $83 — +21.2% $68.45
2025-12-22 RBC Capital — Initiated $95 — +51.5% $62.72
2025-12-22 Needham Serge Belanger $72 $84 +12 +21.3% $69.25
2025-12-22 Goldman Sachs — $95 $99 +4 +57.8% $62.72
2025-12-22 H.C. Wainwright Joseph Pantginis $120 $136 +16 +116.8% $62.72
2025-12-22 Barclays — $82 $87 +5 +38.7% $62.72
2025-12-18 Goldman Sachs — $60 $95 +35 +58.8% $59.82
2025-12-01 UBS Ashwani Verma Initiated $61 — -9.3% $67.23
2025-10-06 Barclays Gena Wang $71 $82 +11 +43.9% $56.97
2025-09-03 Evercore ISI Cory Kasimov Initiated $80 — +60.0% $49.99
2025-09-03 Barclays Gena Wang $55 $71 +16 +42.0% $49.99
2025-09-02 Stifel Nicolaus James Condulis Initiated $96 — +93.5% $49.62
2025-04-24 Barclays Gena Wang $95 $55 -40 +36.4% $40.33
2025-03-06 Morgan Stanley — $45 $67 +22 +54.8% $43.27
2024-10-17 H.C. Wainwright Joseph Pantginis $90 $120 +30 +117.1% $55.28
2024-09-03 Goldman Sachs Paul Choi Initiated $60 — +10.0% $54.56
2024-06-10 Piper Sandler Yasmeen Rahimi $72 $107 +35 +101.1% $53.21
2024-06-04 B.Riley Financial Mayank Mamtani Initiated $92 — +88.9% $48.70
2024-05-28 JMP Securities Jason Butler $106 $78 -28 +61.5% $48.30
2024-05-23 H.C. Wainwright Joseph Pantginis $75 $90 +15 +84.8% $48.71
2024-05-23 Needham Serge Belanger $58 $72 +14 +21.6% $59.23
2024-05-23 Jefferies Akash Tewari Initiated $85 — +43.5% $59.23
2024-05-23 Barclays Carter Gould $52 $95 +43 +60.4% $59.23
2024-05-09 Oppenheimer Justin Kim Initiated $106 — +62.4% $65.27
2024-05-09 JMP Securities Jason Butler Initiated $106 — +62.4% $65.27
2024-04-05 Mizuho Securities Salim Syed Initiated $99 — +36.1% $72.74

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
Oct 27, 2026
DCF
1
ROE
5
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CYTK receives an overall rating of C. Strongest factors: ROE (5/5). Areas of concern: DCF (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 11 Grade D
Profitability
20
Balance Sheet
32
Earnings Quality
18
Growth
19
Value
32
Momentum
25
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CYTK scores highest in Balance Sheet (32/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-0.37
Distress Zone
Piotroski F-Score
2/9
✗ ✗ ✗ ✓ ✓ ✗ ✗ ✗ ✗
Beneish M-Score
1.00
Possible Manipulator
Ohlson O-Score
-3.95
Bankruptcy prob: 1.9%
Low Risk
Credit Rating
B-
Score: 20.0/100
Trend: Stable
Earnings Quality
—
OCF/NI: 0.62x
Accruals: -21.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CYTK scores -0.37, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CYTK scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CYTK's score of 1.00 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CYTK's implied 1.9% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CYTK receives an estimated rating of B- (score: 20.0/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-8.53x
PEG
0.26x
P/S
120.53x
P/B
-46.84x
P/FCF
-19.38x
P/OCF
—
EV/EBITDA
-13.82x
EV/Revenue
160.05x
EV/EBIT
-13.61x
EV/FCF
-19.56x
Earnings Yield
-7.94%
FCF Yield
-5.16%
Shareholder Yield
0.19%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. CYTK currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.072
EBT / EBIT
×
EBIT Margin
-11.758
EBIT / Rev
×
Asset Turnover
0.045
Rev / Assets
×
Equity Multiplier
-5.810
Assets / Equity
=
ROE
329.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CYTK's ROE of 329.8% is driven by Asset Turnover (0.045), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$61.52
Median 1Y
$60.37
5th Pctile
$20.52
95th Pctile
$176.54
Ann. Volatility
67.5%
Analyst Target
$110.50
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Robert I. Blum,
Principal Executive Officer
$853,069 $5,150,019 $11,881,456
Jeffrey Hessekiel, President,
Vice President, Chief Legal & Administrative Officer
$85,250 $5,800,013 $6,086,217
Fady I. Malik,
Executive Vice President, Research and Development
$629,781 $1,750,002 $4,467,066
Andrew M. Callos,
Executive Vice President, Chief Commercial Officer
$581,678 $1,449,995 $3,787,644
Sung H. Lee,
Principal Financial Officer
$572,918 $1,449,995 $3,770,807

CEO Pay Ratio

5:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $2,177,957
Avg Employee Cost (SGA/emp): $422,394
Employees: 673

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
673
+35.1% YoY
Revenue / Employee
$130,816
Rev: $88,039,000
Profit / Employee
$-1,166,352
NI: $-784,955,000
SGA / Employee
$422,394
Avg labor cost proxy
R&D / Employee
$603,122
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -1.1% -1.2% -2.8% -3.4% -2.4% -5.7% 7.6% 4.9% 2.3% 2.1% 1.7% 4.9% 2.5% 2.3% 1.9% 4.7% 2.8% 2.0% 1.5% 3.3% 3.30%
ROA -35.1% -31.3% -36.0% -32.3% -29.6% -41.9% -49.3% -69.6% -58.0% -57.2% -62.5% -47.3% -53.0% -53.0% -59.4% -44.1% -52.4% -55.5% -65.4% -56.8% -56.76%
ROIC -4.2% -3.5% 1.0% 94.3% 1.2% 1.8% 2.1% 2.5% 1.7% 1.6% 1.5% 2.5% 1.8% 1.0% 1.1% 1.2% 1.6% 1.9% 1.4% 8.1% 8.11%
ROCE -26.5% -24.2% -28.6% -25.7% -23.9% -36.3% -46.1% -67.3% -70.9% -64.9% -65.2% -33.3% -37.4% -41.2% -47.4% -47.0% -50.7% -58.2% -69.4% -47.9% -47.86%
Gross Margin -7.9% 21.8% -39.0% 35.8% -23.9% -37.3% -16.2% -95.0% -217.3% -49.8% -96.7% -318.7% -181.7% -4.5% -62.2% 96.6% -38.4% 83.9% 87.6% 91.4% 91.44%
Operating Margin -12.7% -39.0% -67.8% -12.2% -43.1% -64.9% -27.0% -140.8% -323.5% -76.2% -151.2% -522.8% -304.1% -8.2% -98.6% -1.7% -86.1% -10.0% -9.5% -5.5% -5.51%
Net Margin -14.0% -55.0% -77.9% -22.3% -56.6% -70.2% -28.5% -148.4% -342.4% -81.9% -162.4% -575.6% -346.7% -8.9% -102.2% -2.0% -158.1% -10.3% -10.6% -6.2% -6.23%
EBITDA Margin -12.6% -34.9% -68.4% -9.0% -49.5% -60.5% -25.0% -129.7% -300.5% -67.9% -138.9% -468.3% -293.4% -7.4% -86.2% -1.6% -143.2% -10.2% -8.7% -6.1% -6.11%
FCF Margin -3.9% -2.7% -2.8% -1.6% -1.8% -3.3% -4.1% -43.7% -56.7% -55.2% -112.2% -127.5% -126.5% -21.6% -21.3% -5.1% -5.2% -6.1% -5.2% -8.2% -8.18%
OCF Margin -2.1% -2.0% -2.2% -1.3% -1.6% -3.1% -4.0% -42.6% -56.1% -55.0% -112.4% -127.3% -125.6% -21.4% -20.7% -5.0% -5.0% -5.8% -5.0% -7.8% -7.83%
ROA 3Y Avg snapshot only -43.90%
ROIC Economic snapshot only -50.81%
Cash ROA snapshot only -28.86%
NOPAT Margin snapshot only -7.84%
Pretax Margin snapshot only -12.60%
R&D / Revenue snapshot only 5.55%
SGA / Revenue snapshot only 5.22%
SBC / Revenue snapshot only 1.36%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -12.55 -17.80 -12.14 -15.60 -16.10 -11.15 -7.77 -5.79 -5.37 -15.72 -13.47 -10.85 -10.78 -9.42 -7.74 -6.51 -8.77 -9.91 -9.79 -12.59 -8.533
P/S Ratio 133.22 54.42 48.11 22.28 30.65 45.87 34.15 313.86 362.16 1098.42 1904.56 1888.52 1930.34 300.65 247.81 46.03 75.61 88.36 76.78 158.57 120.528
P/B Ratio 11.53 15.72 26.91 30.23 -284.32 -40.21 -14.62 -9.38 -6.45 -21.41 -18.04 54.52 -446.68 -41.03 -17.88 -10.70 -12.65 -11.79 -9.83 -64.86 -46.839
P/FCF -34.46 -20.03 -17.10 -14.27 -16.85 -14.07 -8.30 -7.19 -6.39 -19.89 -16.98 -14.81 -15.27 -13.89 -11.63 -8.96 -14.54 -14.55 -14.80 -19.38 -19.377
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -13.56 -19.98 -12.89 -17.80 -19.16 -13.07 -9.38 -7.03 -6.61 -18.50 -15.99 -12.29 -12.43 -10.67 -8.99 -7.82 -10.57 -11.66 -11.70 -13.82 -13.817
EV/Revenue 123.42 51.56 43.70 20.55 29.78 45.52 35.03 332.31 388.93 1117.14 1940.79 1803.33 1861.36 285.10 240.15 46.03 78.30 92.93 81.23 160.05 160.052
EV/EBIT -13.42 -19.52 -12.59 -17.14 -18.49 -12.75 -9.14 -6.88 -6.47 -17.95 -15.53 -11.96 -12.09 -10.47 -8.82 -7.68 -10.41 -11.50 -11.53 -13.61 -13.612
EV/FCF -31.93 -18.97 -15.53 -13.16 -16.38 -13.96 -8.52 -7.61 -6.86 -20.23 -17.30 -14.15 -14.72 -13.17 -11.28 -8.96 -15.06 -15.30 -15.66 -19.56 -19.557
Earnings Yield -8.0% -5.6% -8.2% -6.4% -6.2% -9.0% -12.9% -17.3% -18.6% -6.4% -7.4% -9.2% -9.3% -10.6% -12.9% -15.4% -11.4% -10.1% -10.2% -7.9% -7.94%
FCF Yield -2.9% -5.0% -5.8% -7.0% -5.9% -7.1% -12.0% -13.9% -15.7% -5.0% -5.9% -6.8% -6.6% -7.2% -8.6% -11.2% -6.9% -6.9% -6.8% -5.2% -5.16%
PEG Ratio snapshot only 0.255
EV/Gross Profit snapshot only 188.356
Shareholder Yield snapshot only 0.19%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 6.12 7.45 9.33 9.01 11.56 9.40 9.05 8.94 7.22 6.12 7.19 10.39 9.28 6.17 5.99 6.76 6.88 4.53 4.21 6.66 6.661
Quick Ratio 6.12 7.45 9.33 9.01 11.56 9.40 9.05 8.94 7.22 6.12 7.19 10.39 9.28 6.17 5.99 6.76 6.88 4.53 4.21 6.66 6.659
Debt/Equity 1.07 1.11 2.77 2.91 -46.25 -6.95 -3.28 -2.25 -1.71 -1.96 -1.91 7.28 -56.76 -5.83 -2.97 -2.33 -2.30 -1.95 -1.56 -7.32 -7.324
Net Debt/Equity -0.85 -0.83 -2.47 -2.35 — — — — — — — -2.46 — — — — — — — — —
Debt/Assets 0.32 0.32 0.38 0.42 0.69 0.74 0.84 0.96 1.01 0.92 0.93 0.52 0.55 0.56 0.63 0.70 0.83 0.90 1.01 0.66 0.660
Debt/EBITDA -1.36 -1.49 -1.46 -1.86 -3.21 -2.28 -2.05 -1.59 -1.63 -1.66 -1.66 -1.72 -1.64 -1.60 -1.54 -1.70 -1.85 -1.83 -1.75 -1.55 -1.546
Net Debt/EBITDA 1.08 1.11 1.30 1.50 0.56 0.10 -0.24 -0.39 -0.46 -0.31 -0.30 0.58 0.46 0.58 0.29 0.00 -0.36 -0.57 -0.64 -0.13 -0.128
Interest Coverage -6.49 -6.26 -7.00 -5.16 -5.46 -6.60 -6.82 -8.20 -8.26 -8.13 -7.59 -6.50 -6.12 -5.81 -5.68 -5.58 -6.82 -6.85 -6.53 -6.68 -6.684
Equity Multiplier 3.32 3.45 7.36 6.93 -67.34 -9.40 -3.89 -2.34 -1.69 -2.13 -2.04 14.04 -103.23 -10.35 -4.74 -3.32 -2.76 -2.16 -1.54 -11.09 -11.093
Cash Ratio snapshot only 6.425
Debt Service Coverage snapshot only -6.585
Cash to Debt snapshot only 0.917
FCF to Debt snapshot only -0.457
Defensive Interval snapshot only 567.9 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.03 0.10 0.09 0.23 0.16 0.10 0.11 0.01 0.01 0.01 0.00 0.00 0.00 0.02 0.02 0.06 0.06 0.06 0.08 0.05 0.045
Inventory Turnover — — — — — — — — — — — — — — — — — — 132.69 56.12 56.121
Receivables Turnover 7.68 2.50 12.30 64.68 100.91 3.64 27.77 6.73 3.26 10.53 4.08 6.36 2.35 2.06 13.51 20.39 85.00 10.58 23.94 4.32 4.321
Payables Turnover 12.69 10.98 12.63 13.45 13.66 10.31 14.75 22.55 22.69 14.01 21.91 29.84 26.07 16.21 26.58 21.82 11.79 1.71 0.53 0.58 0.580
DSO 48 146 30 6 4 100 13 54 112 35 89 57 156 177 27 18 4 35 15 84 84.5 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 7 6.5 days
DPO 29 33 29 27 27 35 25 16 16 26 17 12 14 23 14 17 31 214 690 629 628.8 days
Cash Conversion Cycle 19 112 1 -22 -23 65 -12 38 96 9 73 45 142 155 13 1 -27 -179 -672 -538 -537.8 days
Fixed Asset Turnover snapshot only 0.467
Operating Cycle snapshot only 91.0 days
Cash Velocity snapshot only 0.061
Capital Intensity snapshot only 27.122
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue -60.3% 26.2% 11.1% 1.6% 5.9% 34.3% 50.8% -93.4% -94.7% -92.0% -96.2% -68.5% -58.8% 1.5% 4.1% 26.4% 26.1% 3.8% 4.5% -17.2% -17.24%
Net Income -1.0% -69.2% -90.9% -38.6% -23.4% -80.6% -67.2% -1.5% -86.7% -35.3% -23.2% -1.0% -9.4% -12.0% -16.0% -11.2% -30.5% -33.2% -34.8% -47.4% -47.45%
EPS -70.5% -42.5% -59.9% -16.0% -5.7% -60.4% -49.3% -1.2% -82.2% -29.3% -15.0% 11.4% 10.7% 6.0% 0.3% -1.7% -28.0% -28.4% -29.6% -33.4% -33.35%
FCF -22.4% -89.8% -24.9% -12.8% -2.2% -61.2% -1.2% -84.1% -64.4% -34.8% -4.3% 8.1% 8.1% 3.8% 2.7% -10.3% -11.4% -33.8% -34.1% -31.8% -31.84%
EBITDA -1.6% -1.1% -1.2% -43.1% -17.5% -81.2% -66.0% -1.7% -99.5% -38.1% -24.4% 2.3% -4.8% -8.5% -12.8% -9.8% -34.1% -42.1% -43.0% -62.8% -62.82%
Op. Income -1.5% -98.3% -1.1% -41.9% -8.9% -74.0% -65.9% -1.7% -1.3% -53.1% -34.3% -5.0% -5.8% -8.1% -13.6% -8.1% -9.2% -14.2% -13.2% -28.8% -28.82%
OCF Growth snapshot only -30.11%
Asset Growth snapshot only 57.02%
Debt Growth snapshot only 48.07%
Shares Change snapshot only 10.57%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y -0.8% 30.8% 23.3% 61.9% 68.4% 52.1% 64.0% -18.9% -47.6% -48.7% -60.0% -62.2% -46.9% -36.0% -33.4% -17.2% -16.2% -2.4% 2.6% 92.5% 92.47%
Revenue 5Y -23.6% -7.9% -8.6% 8.7% 26.1% 47.9% 46.6% -10.8% -18.8% -24.9% -35.9% -38.5% -36.4% -7.2% -2.9% 35.6% 9.9% 9.5% 12.6% 4.2% 4.19%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y 53.2% 58.5% 62.8% 57.3% 79.1% 51.9% 51.4% 49.7% 16.0% 15.6% 11.9% 39.3% 20.2% 18.5% 13.9% 16.7% 10.1% 12.0% 12.7% 35.1% 35.13%
Assets 5Y 39.2% 37.7% 26.4% 17.8% 26.9% 28.0% 26.0% 25.8% 26.3% 31.3% 32.4% 50.4% 50.3% 37.1% 37.6% 39.4% 24.8% 21.7% 17.2% 27.8% 27.81%
Equity 3Y 68.5% 1.1% 2.3% — — — — — — — — 87.4% — — — — — — — — —
Book Value 3Y 48.2% 82.9% 1.8% — — — — — — — — 62.9% — — — — — — — — —
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.42 0.15 0.16 0.06 0.28 0.94 0.89 0.11 0.05 0.00 0.00 0.04 0.02 0.05 0.03 0.00 0.03 0.00 0.00 0.10 0.100
Earnings Stability 0.81 0.71 0.74 0.81 0.81 0.65 0.69 0.61 0.77 0.86 0.89 0.82 0.92 0.95 0.96 0.88 0.97 0.99 0.99 0.92 0.917
Margin Stability 0.00 0.10 0.13 0.00 0.00 0.13 0.29 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.00 1.00 1.00 1.00 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.50 0.85 0.91 0.50 0.50 0.50 0.50 0.86 0.91 1.00 0.96 0.95 0.94 0.96 0.88 0.87 0.86 0.81 0.810
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend — — — — — — — — — — — — — — — — — — — — —
Gross Margin Trend -4.50 0.20 0.13 1.96 2.76 -0.54 -0.55 -28.49 -36.88 -41.43 -85.82 -89.14 -81.56 4.82 27.07 64.26 69.58 29.88 53.49 53.92 53.922
FCF Margin Trend -1.86 -0.96 -0.56 1.29 0.74 -1.88 -2.65 -42.74 -53.85 -52.22 -108.69 -104.87 -97.20 7.60 36.84 80.44 86.37 32.35 61.54 58.12 58.125
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.20 0.66 0.54 0.93 0.86 0.76 0.91 0.79 0.83 0.79 0.79 0.73 0.70 0.67 0.65 0.70 0.58 0.65 0.63 0.62 0.621
FCF/OCF 1.83 1.34 1.31 1.18 1.11 1.04 1.03 1.03 1.01 1.00 1.00 1.00 1.01 1.01 1.03 1.03 1.05 1.05 1.05 1.05 1.045
FCF/Net Income snapshot only 0.650
CapEx/Revenue 1.7% 69.4% 66.4% 23.3% 17.5% 12.0% 11.0% 1.1% 58.1% 18.8% 19.7% 14.6% 83.7% 21.1% 58.9% 15.8% 23.5% 28.2% 23.7% 35.6% 35.60%
CapEx/Depreciation snapshot only 2.043
Accruals Ratio -0.28 -0.11 -0.16 -0.02 -0.04 -0.10 -0.04 -0.15 -0.10 -0.12 -0.13 -0.13 -0.16 -0.17 -0.21 -0.13 -0.22 -0.19 -0.24 -0.21 -0.215
Sloan Accruals snapshot only 0.165
Cash Flow Adequacy snapshot only -21.988
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.3% 0.3% 0.3% 0.2% 0.19%
Net Buyback Yield -10.6% -8.2% -10.0% -9.4% -0.3% -0.4% -0.6% -0.6% -0.8% -2.0% -3.6% -14.7% -14.1% -13.0% -13.3% -0.7% 0.2% 0.1% 0.0% -7.0% -7.01%
Total Shareholder Return -10.6% -8.2% -10.0% -9.4% -0.3% -0.4% -0.6% -0.6% -0.8% -2.0% -3.6% -14.7% -14.1% -13.0% -13.3% -0.7% 0.2% 0.1% 0.0% -7.0% -7.01%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.15 1.16 1.14 1.19 1.18 1.15 1.15 1.12 1.12 1.12 1.13 1.15 1.16 1.17 1.18 1.18 1.15 1.10 1.11 1.07 1.072
EBIT Margin -9.20 -2.64 -3.47 -1.20 -1.61 -3.57 -3.83 -48.33 -60.12 -62.23 -124.96 -150.80 -153.90 -27.23 -27.22 -6.00 -7.52 -8.08 -7.05 -11.76 -11.758
Asset Turnover 0.03 0.10 0.09 0.23 0.16 0.10 0.11 0.01 0.01 0.01 0.00 0.00 0.00 0.02 0.02 0.06 0.06 0.06 0.08 0.05 0.045
Equity Multiplier 3.27 3.85 7.79 10.45 8.17 13.65 -15.48 -7.00 -3.99 -3.72 -2.72 -10.26 -4.81 -4.27 -3.13 -10.57 -5.37 -3.55 -2.32 -5.81 -5.810
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-2.85 $-2.56 $-3.03 $-2.52 $-3.01 $-4.11 $-4.53 $-5.64 $-5.48 $-5.31 $-5.21 $-4.99 $-4.90 $-4.99 $-5.19 $-5.08 $-6.27 $-6.41 $-6.73 $-6.77 $-6.77
Book Value/Share $3.10 $2.90 $1.37 $1.30 $-0.17 $-1.14 $-2.41 $-3.48 $-4.57 $-3.90 $-3.89 $0.99 $-0.12 $-1.15 $-2.25 $-3.09 $-4.34 $-5.39 $-6.71 $-1.31 $-1.31
Tangible Book/Share $3.10 $2.90 $1.37 $1.30 $-0.17 $-1.14 $-2.41 $-3.48 $-4.57 $-3.90 $-3.89 $0.99 $-0.12 $-1.15 $-2.25 $-3.09 $-4.34 $-5.39 $-6.71 $-1.31 $-1.31
Revenue/Share $0.27 $0.84 $0.77 $1.76 $1.58 $1.00 $1.03 $0.10 $0.08 $0.08 $0.04 $0.03 $0.03 $0.16 $0.16 $0.72 $0.73 $0.72 $0.86 $0.54 $0.54
FCF/Share $-1.04 $-2.28 $-2.15 $-2.75 $-2.87 $-3.26 $-4.24 $-4.54 $-4.61 $-4.20 $-4.13 $-3.66 $-3.46 $-3.39 $-3.45 $-3.69 $-3.78 $-4.37 $-4.45 $-4.40 $-4.40
OCF/Share $-0.57 $-1.69 $-1.64 $-2.34 $-2.60 $-3.14 $-4.13 $-4.43 $-4.56 $-4.18 $-4.14 $-3.65 $-3.44 $-3.35 $-3.36 $-3.57 $-3.61 $-4.17 $-4.25 $-4.21 $-4.21
Cash/Share $5.95 $5.61 $7.16 $6.84 $9.25 $8.27 $6.98 $5.91 $5.61 $6.21 $6.07 $9.68 $8.60 $9.11 $7.92 $7.18 $8.02 $7.21 $6.64 $8.83 $8.83
EBITDA/Share $-2.44 $-2.16 $-2.59 $-2.04 $-2.46 $-3.48 $-3.85 $-4.91 $-4.78 $-4.59 $-4.47 $-4.21 $-4.10 $-4.18 $-4.33 $-4.23 $-5.39 $-5.73 $-5.96 $-6.22 $-6.22
Debt/Share $3.32 $3.21 $3.79 $3.78 $7.88 $7.92 $7.88 $7.83 $7.79 $7.63 $7.41 $7.23 $6.71 $6.68 $6.68 $7.18 $9.98 $10.49 $10.45 $9.62 $9.62
Net Debt/Share $-2.63 $-2.40 $-3.37 $-3.06 $-1.37 $-0.34 $0.91 $1.92 $2.18 $1.42 $1.33 $-2.44 $-1.89 $-2.43 $-1.24 $-0.00 $1.95 $3.28 $3.81 $0.79 $0.79
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -0.366
Altman Z-Prime snapshot only -0.373
Piotroski F-Score 1 2 2 5 3 3 3 1 1 1 1 4 5 6 5 3 3 3 3 2 2
Beneish M-Score -6.63 -3.88 0.14 5.50 1.90 -13.00 -0.19 25.73 0.53 5.06 -1.91 -3.86 -1.42 11.18 -0.35 60.38 249.71 -7.19 -31.82 1.00 1.001
Ohlson O-Score snapshot only -3.949
Net-Net WC snapshot only $-6.73
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only B-
Credit Score 31.23 42.05 29.26 29.70 20.00 20.00 20.00 20.00 20.00 20.00 20.00 27.79 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.000
Credit Grade snapshot only 16
Credit Trend snapshot only 0.000
Implied Spread (bps) snapshot only 900.000
Industry Credit Rank snapshot only 16
Sector Credit Rank snapshot only 16

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms